IBDEI1NH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26354,1,3,0)
 ;;=3^DM Type 1 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,26354,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,26354,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,26355,0)
 ;;=E10.29^^107^1240^24
 ;;^UTILITY(U,$J,358.3,26355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26355,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,26355,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,26355,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,26356,0)
 ;;=E10.311^^107^1240^12
 ;;^UTILITY(U,$J,358.3,26356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26356,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,26356,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,26356,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,26357,0)
 ;;=E10.319^^107^1240^13
 ;;^UTILITY(U,$J,358.3,26357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26357,1,3,0)
 ;;=3^DM Type 1 w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,26357,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,26357,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,26358,0)
 ;;=E10.3211^^107^1240^19
 ;;^UTILITY(U,$J,358.3,26358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26358,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,26358,1,4,0)
 ;;=4^E10.3211
 ;;^UTILITY(U,$J,358.3,26358,2)
 ;;=^5138279
 ;;^UTILITY(U,$J,358.3,26359,0)
 ;;=E10.3212^^107^1240^20
 ;;^UTILITY(U,$J,358.3,26359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26359,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,26359,1,4,0)
 ;;=4^E10.3212
 ;;^UTILITY(U,$J,358.3,26359,2)
 ;;=^5138280
 ;;^UTILITY(U,$J,358.3,26360,0)
 ;;=E10.3213^^107^1240^21
 ;;^UTILITY(U,$J,358.3,26360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26360,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,26360,1,4,0)
 ;;=4^E10.3213
 ;;^UTILITY(U,$J,358.3,26360,2)
 ;;=^5138281
 ;;^UTILITY(U,$J,358.3,26361,0)
 ;;=E10.39^^107^1240^26
 ;;^UTILITY(U,$J,358.3,26361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26361,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,26361,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,26361,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,26362,0)
 ;;=E10.40^^107^1240^10
 ;;^UTILITY(U,$J,358.3,26362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26362,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,26362,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,26362,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,26363,0)
 ;;=E10.41^^107^1240^7
 ;;^UTILITY(U,$J,358.3,26363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26363,1,3,0)
 ;;=3^DM Type 1 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,26363,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,26363,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,26364,0)
 ;;=E10.42^^107^1240^11
 ;;^UTILITY(U,$J,358.3,26364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26364,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,26364,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,26364,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,26365,0)
 ;;=E10.43^^107^1240^2
 ;;^UTILITY(U,$J,358.3,26365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26365,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,26365,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,26365,2)
 ;;=^5002607
